Shared Metabolic Profile of Caffeine in Parkinsonian Disorders
Shared Metabolic Profile of Caffeine in Parkinsonian Disorders
复制标题
DOI：
10.1002/mds.28068
复制
发表时间：
2020-05
影响因子：
8.6
通讯作者：
H. Takeshige-Amano;S. Saiki;M. Fujimaki;S. Ueno;Yuanzhe Li;T. Hatano;K. Ishikawa;Y. Oji;A. Mori;A. Okuzumi;T. Tsunemi;K. Daida;Y. Ishiguro;Yoko Imamichi;Hisayoshi Nanmo;S. Nojiri;M. Funayama;N. Hattori
中科院分区：
文献类型：
--
作者：
H. Takeshige-Amano;S. Saiki;M. Fujimaki;S. Ueno;Yuanzhe Li;T. Hatano;K. Ishikawa;Y. Oji;A. Mori;A. Okuzumi;T. Tsunemi;K. Daida;Y. Ishiguro;Yoko Imamichi;Hisayoshi Nanmo;S. Nojiri;M. Funayama;N. Hattori
本研究的目的是确定帕金森病（PD）、进行性核上性麻痹（PSP）和多系统萎缩（MSA）等帕金森综合征患者血清中咖啡因的全面代谢变化，并将其与健康对照血清进行比较。
The objective of this study was to determine comprehensive metabolic changes of caffeine in the serum of patients with parkinsonian disorders including Parkinson's disease (PD), progressive supranuclear palsy (PSP), and multiple system atrophy (MSA) and to compare this with healthy control serum.